Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
First Wave Bio (FWBI)
NASDAQ:FWBI
First Wave Bio (FWBI) Stock Price & Analysis
1,200 Followers
FWBI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.75 - $64.98
Previous Close$3.02
Volume37.95K
Average Volume (3M)120.29K
Market Cap
$6.22M
Enterprise Value$3.56M
Total Cash (Recent Filing)$3.29M
Total Debt (Recent Filing)$231.29K
Price to Earnings (P/E)>-0.1
Beta1.35
Next Earnings
Aug 13, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-86.07
Shares Outstanding2,025,199
10 Day Avg. Volume32,465
30 Day Avg. Volume120,287
Standard Deviation0.26
R-Squared0.07
Alpha-0.13
Financial Highlights & Ratios
Price to Book (P/B)4.15
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-5.99
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.29
Forecast
1Y Price Target
$36.00Price Target Upside1169.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
First Wave Bio News
PremiumCompany Announcements
First Wave Bio Inc. Grapples with Uncertainty in Pending Niclosamide Deal
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FWBI FAQ
What was First Wave Bio’s price range in the past 12 months?
First Wave Bio lowest stock price was $2.75 and its highest was $64.98 in the past 12 months.
What is First Wave Bio’s market cap?
Currently, no data Available
When is First Wave Bio’s upcoming earnings report date?
First Wave Bio’s upcoming earnings report date is Aug 13, 2019 which is 1711 days ago.
How were First Wave Bio’s earnings last quarter?
Currently, no data Available
Is First Wave Bio overvalued?
According to Wall Street analysts First Wave Bio’s price is currently Undervalued.
Does First Wave Bio pay dividends?
First Wave Bio does not currently pay dividends.
What is First Wave Bio’s EPS estimate?
First Wave Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does First Wave Bio have?
First Wave Bio has 2,025,199 shares outstanding.
What happened to First Wave Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of First Wave Bio?
Currently, no hedge funds are holding shares in FWBI
---
First Wave Bio Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$36.00 (1169.84% Upside)
$36.00 (1169.84% Upside)
Blogger Sentiment
Bullish
FWBI Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $17.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.8%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-94.28%
12-Months-Change
Fundamentals
Return on Equity
-497.87%
Trailing 12-Months
Asset Growth
26.54%
Trailing 12-Months
Company Description
First Wave Bio
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It focuses on MS1819-SD, and B-Lactamase program products. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY.
---
FWBI Stock 12 Months Forecast
Average Price Target
$36.00
▲(1169.84% Upside)
Technical Analysis
Best Analysts Covering FWBI
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-49.93%
reiterated a buy rating last month
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -49.93% per trade.
---